The Eye5 model addresses diverse causes of vision loss, from diabetic retinopathy to macular degeneration.
The AI-powered Eye5s have embedded cameras that capture peripheral vision images and use algorithms to enhance the wearer’s views.
The glasses offer a hands-free optic solution to vision loss, and they can be acquired through traditional eye care providers.
“People value their eyesight over 10 times more than any of their other senses. The Eye5 gives my patients with visual impairments access to life-changing technology to enhance their vision. The ability to acquire the smart glasses through their eye care provider makes it more attainable as well,” Mitul Mehta, MD, retinal surgeon and chief medical officer at Eyedaptic, said in an Oct. 24 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.